首页 | 本学科首页   官方微博 | 高级检索  
检索        

下呼吸道革兰阴性菌感染的病原学及耐药分析
引用本文:杨泽刚,王天立,裴文军,杨翠云,胡成平.下呼吸道革兰阴性菌感染的病原学及耐药分析[J].医学临床研究,2006,23(10):1628-1630.
作者姓名:杨泽刚  王天立  裴文军  杨翠云  胡成平
作者单位:1. 湖南省常德市第一人民医院,湖南,常德,415003
2. 中南大学湘雅医院呼吸科,湖南,长沙,410000
摘    要:【目的】了解本地区下呼吸道革兰阴性菌(G^-)感染者的病原学诊断及对常用抗生素的敏感情况。【方法】回顾性分析2002年1月至2004年12月本院下呼吸道感染住院患者痰标本细菌培养分离及药敏试验结果。【结果】分离率前五位的菌种分别为铜绿假单胞菌(34.8%)、不动杆菌(13.5%)、肺炎克雷伯菌(12.9%)、大肠埃希菌(12.3%)和阴沟肠杆菌(5.2%)。所有G^-均有较严重的耐药性,除头孢他啶外,对多数头孢三代药物耐药率高。耐药率较低的抗生素有亚胺培南、美洛培南、哌拉西林/他唑巴坦、头孢吡肟、左氟沙星。其中碳青霉烯类抗生素(亚胺培南、美洛培南)对下呼吸道G^-的敏感率在95%以上。本组分离的下呼吸道G^-对左氟沙星耐药率较低(33%),对阿米卡星的耐药率高(46%),与其他地区的报道存在较大差异。【结论】下呼吸道G^-感染的耐药是目前临床上面临的难题,值得进一步研究,应采用合理的手段降低耐药率的发生。

关 键 词:呼吸道感染  革兰氏阴性菌  抗药性  微生物
文章编号:1671-7171(2006)10-1628-03
收稿时间:2006-07-20
修稿时间:2006年7月20日

Study on the Distribution and Drug Resistance of Gram-negative Bacteria in Patients with Lower Respiratory Tract Infection
Tract Infection YANG Ze-gang, WANG Tian-Li, PEI Weng-jun,et al.Study on the Distribution and Drug Resistance of Gram-negative Bacteria in Patients with Lower Respiratory Tract Infection[J].Journal of Clinical Research,2006,23(10):1628-1630.
Authors:Tract Infection YANG Ze-gang  WANG Tian-Li  PEI Weng-jun  
Institution:The First Hospital of Changde ,Hunan ,415003 ,China
Abstract:Objective]To investigate the distribution of drug resistance of gram-negative bacteria in patients with lower respiratory tract infection in Changde city.Methods]The results of sputum's culture and antimicrobial susceptibility of patients from 2002 to 2004 were reviewed.Results]The most common pathogens were Pseudomonas aeruginosa(34.8%),Acinetobacter spp(13.5%), Klebsiella pneumoniae(12.9%), Escherichia coli (12.3%),Enterobacter cloacae(5.2%). High drug-resistance rates were found among all strains of pathogens to the third generation cephalosporins except ceftazidime. The most sensitive agents against Gram negative organisms were carbopenems(Imipenem,Meropenem),with a susceptibility of more than 95%,followed by Piperacilline/Tazobactam, Cefepime and Levofloxacin. In this study, the drug-resistance rate among gram-negative bacteria from lower respiratory tract to Levofloxacin was 33%,while drug-resistance rate to amikacin was 46%,different from reports of other area.Conclusion]Drug-resistance is still a serious clinical problem. An unanimous effective strategy for the solution of this problem is urgently needed.
Keywords:respiratory tract infections  gram-negtive bacteria  drug resistance  microbial
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号